Liver Disease Treatment Market Growing Fast at a CAGR of 5.7% with a Value of $36,455.70 Million by 2030
Liver Disease Treatment Market size was valued at $20,673.70 Million in 2020 and is projected to reach $36,455.70 Million by 2030
PORTLAND, OREGON, USA, January 20, 2022 /EINPresswire.com/ — According to the Allied Market Research report, titled “liver disease treatment market by type of treatment (antiviral drugs, immunosuppressants, vaccines, immunoglobulins, corticosteroids, targeted therapy, chemotherapy drugs) and type of disease (hepatitis, autoimmune diseases, non-alcoholic fatty liver disease (NAFLD), cancer, genetic disorders and others) : Global Opportunity Industry Analysis and Forecast, 2021-2030″. The report provides in-depth analysis of changing market dynamics, major segments, value chain, key investment pockets, regional scenario and competitive landscape.
The Global Liver Disease Treatment Market Size was valued at USD 20,673.70 Million in 2020 and is projected to reach USD 36,455.70 Million by 2030, growing at a CAGR of 5.7% 2021 to 2030.
For a good perspective and competitive insights, get a sample report on:
Rising incidence of liver disease, increase in governmental and non-governmental awareness programs and increasing geriatric population coupled with increased alcohol consumption and unhealthy eating habits have spurred the growth of the global liver disease treatment market. However, stringent regulatory approvals related to drugs and vaccines for the treatment of liver diseases and resistance to antiviral drugs used in the treatment of hepatitis B and C are hampering the market growth. On the contrary, the presence of strong pipelined products is expected to open up new opportunities for market players in the future.
The growth of the global liver disease treatment market is attributed to increasing prevalence of liver disease, increase in drug discovery and research, development activities of safe and effective therapies. Additionally, rising alcohol consumption, obesity, and increasing healthcare expenditure are expected to drive the market growth over the forecast years.
Comprehensive competitive analysis and profiles of major market players, such as
• AbbVie Inc.
• Astellas Pharma Inc.
• Abbott Laboratories
• Eli Lilly and company
• Bristol Myers Squibb
• Emerging BioSolutions (Cangene bioPharma)
• F. Hoffman-LA Roche
• Merck & Co., Inc. (Merck Sharp & Dohme Corp.)
• Gilead Sciences, Inc.
• Viatris inc.
KEY FINDINGS OF THE STUDY
• By treatment type, antiviral drugs were the top contributor to the liver disease treatment market in 2020.
• By disease type, the hepatitis segment showed the highest growth in 2020 and is expected to continue this trend during the forecast period.
• By region, North America generated the largest revenue share in 2020, while Asia-Pacific is expected to grow at the highest CAGR during the forecast period.
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and templates
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. DEFINITION AND SCOPE OF THE MARKET
3.2. MAIN FINDINGS
3.2.1. The best investment pockets
3.2.2. The best winning strategies
3.3. ANALYSIS OF MARKET SHARE/TOP PLAYER POSITIONING
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
Get Detailed COVID-19 Impact Analysis @ Customization Request:-
FREQUENTLY ASKED QUESTIONS?
Q1. What is the market value of the Liver Disease Treatment Market report during the forecast period?
Q2. What would be the forecast period in the market report?
Q3. What is the liver disease treatment market market value in 2021?
Q4. What is the base year calculated in the Liver Disease Treatment market report?
Q5. Is Liver Disease Treatment Market Company Profiled in the Report?
Q6. Which are the major companies holding the market share in the liver disease treatment market?
Q7. Does Liver Disease Treatment Market Report Provide Value Chain Analysis?
Q8. What are the key trends in the Liver Disease Treatment market report?
Avenue Basic Plan | Access to the library | 1 year subscription |
Sign up for the Avenue subscription to access over 12,000 business profiles and over 2,000 niche market research reports at $699 per month, per seat. For one year, the customer must purchase a minimum 2-seat plan.
14-day free trial request: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published some syndicated market studies in the same field that you may be interested in. Below is the title of the report for your reference, considering the impact of Covid-19 on this market, which will help you to assess the impact of the pandemic on the short and long-term growth trends of this market.
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of “market research reports” and “Business Intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.
Pawan Kumar, CEO of Allied Market Research, leads the organization in delivering high quality data and insights. We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. All data presented in the reports we publish are drawn from primary interviews with senior managers of large companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.